GlassScriptPhysician profile
Sandra A Carey
NPI 1982671319
$27,775.83
in general payments reported to CMS, 2019-2025
24 companies · $3,853 in 2025
The $3,853 reported for 2025 was more than what 97% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,863 · 2022: $11K · 2023: $2,074 · 2024: $4,513 · 2025: $3,853.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,302 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,980 · Consulting Fee: $1,200 · Travel and Lodging: $958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,302.17 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,980.00 |
| Consulting Fee | $1,200.00 |
| Travel and Lodging | $957.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $8,518.13 | 2021-2024 | Remede System |
| Alnylam Pharmaceuticals INC. | $5,029.89 | 2024-2025 | Amvuttra |
| Itamar Medical INC | $5,000.16 | 2022-2025 | Watchpatone |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4,800.61 | 2022-2023 | Lifevest |
| Abbott Laboratories | $2,000.32 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $1,111.06 | 2021-2025 | |
| Inspire Medical Systems, INC. | $308.48 | 2021-2025 | Inspire |
| Cvrx, INC. | $197.76 | 2023-2025 | Barostim Neo System |
| Abiomed | $130.31 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.90 | 2021-2022 | |
| Analog Devices INC. | $108.49 | 2025 | Sensinel Cpm Wearable |
| E.R. Squibb & Sons, L.L.C. | $91.76 | 2025 | Camzyos |
| Novo Nordisk INC | $56.46 | 2021-2025 | Ozempic |
| Actelion Pharmaceuticals US, INC. | $53.32 | 2025 | Uptravi |
| Astrazeneca Pharmaceuticals LP | $32.15 | 2025 | Wainua |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $28.68 | 2025 | Prolastin-C Liquid |
| Daiichi Sankyo INC. | $28.39 | 2023 | Injectafer |
| Ancora Heart, INC. | $25.95 | 2025 | Accucinch |
| Genzyme Corporation | $25.87 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.49 | 2022 | |
| Chiesi USA, INC. | $25.46 | 2024 | Cleviprex, Kengreal |
| Dexcom, INC. | $22.14 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $17.26 | 2025 | Verquvo |
| Medtronic, INC. | $13.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Carey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.